Efficacy of recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis.
Phase 1
- Conditions
- acute exacerbation of idiopathic pulmonary fibrosis
- Registration Number
- JPRN-UMIN000009082
- Lead Sponsor
- Toho university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1)A person having an infection of apparent activity 2)Those who have apparent congestive heart failure. 3) Those who have apneumothorax 4) Those who have athma 5) Those who have deep vein thrombosis to be treated. 6) Who has the possibility of pulmonary arterial thromboembolism 7) A person who has circulatory failure, renal failure, liver failure 8) Those who have intracranial hemorrhage, pulmonary hemorrhage, gastrointestinal bleeding 9)A person with a history of hypersensitivity to components of the thrombomodulin 10) Women who may be pregnant or are pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method